Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets

被引：1
|
作者：
Dalakoti, Mayank [1 ,2 ,3 ]
Virani, Salim [4 ,5 ,6 ]
机构：
[1] Natl Univ Heart Ctr, Dept Cardiol, Singapore, Singapore
[2] Ng Teng Fong Gen Hosp, Dept Med, Singapore, Singapore
[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England
[4] Aga Khan Univ, Dept Med, Karachi, Pakistan
[5] Texas Heart Inst, Houston, TX USA
[6] Baylor Coll Med, Sect Cardiovasc Res, Houston, TX USA
来源：
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2024年 / 19卷
关键词：
Keywords; LDL-C; Primary prevention; Primordial prevention; Preventive cardiology; Lipids; CHOLESTEROL; MANAGEMENT;
D O I：
10.1016/j.ajpc.2024.100720
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Recent Molecular Mechanisms and Beneficial Effects of Phytochemicals and Plant-Based Whole Foods in Reducing LDL-C and Preventing Cardiovascular Disease
    Islam, Salman Ul
    Ahmed, Muhammad Bilal
    Ahsan, Haseeb
    Lee, Young-Sup
    ANTIOXIDANTS, 2021, 10 (05)
  • [42] Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China
    Wang, Xing
    He, Yan
    Wang, Tao
    Li, Chunming
    Ma, Zihui
    Zhang, Heng
    Ma, Handong
    Zhao, Hongxin
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (04) : 307 - 315
  • [43] Novel therapies to achieve the recommended low-density lipoprotein cholesterol concentration (LDL-C) targets for patients after coronary artery bypass grafting
    V. Deo, Salil
    Al-Kindi, Sadeer
    Virani, Salim S.
    Fremes, Stephen
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 167 (02):
  • [44] Higher prevalence of elevated LDL-C than non-HDL-C and low statin treatment rate in elderly community-dwelling Chinese with high cardiovascular risk
    Kuang, YaShu
    Li, Xiaolin
    Chen, Xiaoli
    Sun, Huimin
    Tomlinson, Brian
    Chan, Paul
    Zheng, Liang
    Pi, Jinjiang
    Peng, Sheng
    Wu, Hong
    Ding, Xugang
    Qian, Dingguang
    Shen, Yixin
    Yu, Zuoren
    Fan, Lieying
    Chen, Ming
    Fan, Huimin
    Liu, Zhongmin
    Zhang, Yuzhen
    SCIENTIFIC REPORTS, 2016, 6
  • [45] Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease
    Toth, Peter P.
    Foody, JoAnne M.
    Tomassini, Joanne E.
    Sajjan, Shiva G.
    Ramey, Dena R.
    Neff, David R.
    Tershakovec, Andrew M.
    Hu, Henry
    Tunceli, Kaan
    JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (01) : 107 - 116
  • [46] Quantifying Unmet Need in Statin-Treated Hyperlipidemia Patients and the Potential Benefit of Further LDL-C Reduction Through an EHR-Based Retrospective Cohort Study
    Schleyer, Titus
    Hui, Siu
    Wang, Jane
    Zhang, Zuoyi
    Knapp, Kristina
    Baker, Jarod
    Chase, Monica
    Boggs, Robert
    Simpson, Ross J., Jr.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (05): : 544 - +
  • [47] Failure of LDL-C goals achievement and underuse of lipid-lowering therapies in patients at high and very high cardiovascular risk: Spanish subset from the European SANTORINI study
    Mostaza, J. M.
    Garcia-Ortiz, L.
    Tembra, M. A. Suarez
    Calle, P. Talavera
    Garcia, J. Chimeno
    Perez, V. Escolar
    Diaz-Diaz, J. L.
    Manzano-Espinosa, L.
    Catapano, A. L.
    Ray, K. K.
    Moya, G. Diaz
    Montoya, J. Pedro-Botet
    REVISTA CLINICA ESPANOLA, 2025, 225 (02): : 78 - 84
  • [48] Elevated LDL-c may warn of the risk of gallbladder stones in the patients with metabolic dysfunction-associated steatotic liver disease: A case-control study
    Zhao, Guifen
    Shi, Ran'geng
    Ma, Mao
    Lin, Hairong
    Zhang, Jianqin
    Sheng, Binwu
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (06)
  • [49] Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States
    Baum, Seth J.
    Rane, Pallavi B.
    Nunna, Sasikiran
    Habib, Mohdhar
    Philip, Kiran
    Sun, Kainan
    Wang, Xin
    Wade, Rolin L.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 6
  • [50] Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
    Zhang, Shuang
    Li, Zhi-Fan
    Shi, Hui-Wei
    Zhang, Wen-Jia
    Sui, Yong-Gang
    Li, Jian-Jun
    Dou, Ke-Fei
    Qian, Jie
    Wu, Na-Qiong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345